MedTrace Logo

Danish Angle Closure Prevention Trial

NCT06077253 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 242

Last updated 2023-11-13

No results posted yet for this study

Summary

To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.

Conditions

  • Primary Angle Glaucoma Closure Suspect

Interventions

PROCEDURE

Iridotomy

Peripheral iridotomy (size \>200µm)

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Niklas Telinius · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2029-09-01
Completion
2029-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06077253 on ClinicalTrials.gov